Canada markets closed

Tryp Therapeutics Inc. (TRYP.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
0.06000.0000 (0.00%)
At close: 02:08PM EDT
Currency in CAD

Valuation Measures4

Market Cap (intraday) 5.79M
Enterprise Value 8.73M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)8.43
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -2.15

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-14.29%
S&P500 52-Week Change 322.38%
52 Week High 30.1100
52 Week Low 30.0100
50-Day Moving Average 30.0375
200-Day Moving Average 30.0523

Share Statistics

Avg Vol (3 month) 351.35k
Avg Vol (10 day) 3178.59k
Shares Outstanding 596.42M
Implied Shares Outstanding 696.42M
Float 8154.01M
% Held by Insiders 10.70%
% Held by Institutions 10.00%
Shares Short (Mar 15, 2024) 41.12k
Short Ratio (Mar 15, 2024) 40.08
Short % of Float (Mar 15, 2024) 4N/A
Short % of Shares Outstanding (Mar 15, 2024) 40.00%
Shares Short (prior month Feb 15, 2024) 41.12k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Aug 31, 2023
Most Recent Quarter (mrq)Feb 29, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-55.90%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-2.95M
Diluted EPS (ttm)-0.0400
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.26M
Total Cash Per Share (mrq)0
Total Debt (mrq)15.92M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.08
Book Value Per Share (mrq)-0.06

Cash Flow Statement

Operating Cash Flow (ttm)-6.22M
Levered Free Cash Flow (ttm)46.21k